Directory
Aida Perramon Güell

Aida Perramon Güell

Degree: Master’s degree

2951/2943
aperramon(ELIMINAR)@irblleida.cat

Publications

  • Altés, G; Olomí, A; Perramon-Guell, A; Hernandez, S; CASANOVAS, A; Perez, A; Diaz-Tocados, JM; Valdivielso, JM; Megino, C; Navaridas, R; Matias-Guiu, X; Klein, OD; Egea, J; Dolcet, X; Yeramian, A; Encinas, M

    Multiple endocrine defects in adult-onset Sprouty1/2/4 triple knockout mice

    SCIENTIFIC REPORTS 14 -. .

    [doi:10.1038/s41598-024-70529-w]

  • Anerillas, C; Perramon-Güell, A; Altes, G; Cuesta, S; Vaquero, M; Olomi, A; Rodriguez-Barrueco, R; Llobet-Navàs, D; Egea, J; Dolcet, X; Yeramian, A; Encinas, M

    Sprouty1 is a broad mediator of cellular senescence

    CELL DEATH & DISEASE 15 296-296. .

    [doi:10.1038/s41419-024-06689-4]

  • Ruiz-Mitjana, A; Vidal-Sabanés, M; Navaridas, R; Perramon-Güuell, A; Yeramian, A; Nicholson-Sabate, N; Egea, J; Encinas, M; Matias-Guiu, X; Dolcet, X

    Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-ß and p38/ERK MAPK signalling

    BIOMEDICINE & PHARMACOTHERAPY 168 115817-115817. .

    [doi:10.1016/j.biopha.2023.115817]

  • Navaridas, R; Vidal-Sabanés, M; Ruiz-Mitjana, A; Altés, G; Perramon-Güell, A; Yeramian, A; Egea, J; Encinas, M; Gatius, S; Matias-Guiu, X; Dolcet, X

    In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers

    Advanced Science 10 -. .

    [doi:10.1002/advs.202303134]

  • Navaridas R; Vidal-Sabanés M; Ruiz-Mitjana A; Perramon-Güell A; Megino-Luque C; Llobet-Navas D; Matias-Guiu X; Egea J; Encinas M; Bardia L; Colombelli J; Dolcet X

    Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis.

    Cancer Communications 43 620-624. .

    [doi:10.1002/cac2.12409]

Projects

  • INVESTIGO 2022: Senyalització oncogènica i del desenvolupament